The 2024 Must-Attend Conference on Hematologic Malignancies

For 24 years, the Lymphoma, Leukemia & Myeloma Congress has stood as the premier educational conference dedicated to hematologic malignancies. Every October, over 75 experts from around the world gather in New York to review the latest clinical evidence, debate optimal treatment strategies, and share best practices with one of the largest live audiences in the field.

Our rigorous scientific program includes presentations, panel discussions, and debates covering all areas of blood cancer and emphasizes in-depth learning and active participation. The collaboration and interaction of our comprehensive single-track agenda fosters the exchange of ideas in a practical and hands-on format.

By bringing together the world’s leading educators to discuss the latest scientific advances, we equip our audience with the tools to advance the treatment of hematologic malignancies, improve quality of life, and create better patient outcomes.

Congress Highlights

Don't miss out on this exceptional and vibrant program that offers four days of in-depth learning. Join us as we delve into emerging data, explore groundbreaking treatment methods, and catch a glimpse of what the future holds for lymphoma, myeloma, and leukemia disorders.

  • 24
    Years of Exploration
  • 60+
    Renowned Faculty
  • 1000
  • 25+
    CME Credits

Who Should Attend

Join us in New York City or Virtual. This hybrid event is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with hematologic malignancies. 25+ credit hours are available!

  • Hematologists
  • Medical Oncologists
  • Physicians
  • Physician Assistants
  • Physicians in Training
  • Oncology Nurses
  • Nurse Practitioners
  • Pharmacists

2024 Endorsers

  • The best congress for keeping the treating hematologist up-to-date!”

    2023 Lymphoma, Leukemia & Myeloma Congress Attendee
  • I like the size of the conference, intimate and packed with education, sectioned off according to disease state.”

    2023 Lymphoma, Leukemia & Myeloma Congress Attendee
  • I have gained a wealth of knowledge ... in the field of oncology, thereby building my confidence to better perform my work, collaborate with my team, and care for the patients. Simply worth attending this conference!”

    2023 Lymphoma, Leukemia & Myeloma Congress Attendee

Stay Informed